Is Namzaric a Controlled Substance? No

No. Namzaric (memantine and donepezil) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and memantine and donepezil is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Namzaric?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Namzaric
Source	What it lists
FDA NDC directory	4 prescription listings from 1 labelers, none with a DEA schedule
DEA controlled substances list	memantine and donepezil is not on the list

Namzaric NDC listings

NDC listings for Namzaric
NDC	Product	Form	Strength	Labeler	DEA schedule
0456-1214	Namzaric	capsule	14 mg/1; 10 mg/1	Allergan, Inc.	None
0456-1221	Namzaric	capsule	21 mg/1; 10 mg/1	Allergan, Inc.	None
0456-1228	Namzaric	capsule	28 mg/1; 10 mg/1	Allergan, Inc.	None
0456-1207	Namzaric	capsule	7 mg/1; 10 mg/1	Allergan, Inc.	None

Questions

Is Namzaric a controlled substance?

No. Namzaric (memantine and donepezil) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and memantine and donepezil is not on the DEA controlled substances list.

Is Namzaric a narcotic?

No. Namzaric (memantine and donepezil) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Cholinesterase Inhibitor and N-methyl-D-aspartate Receptor Antagonist.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.